Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
This guide highlights the widely used indices in finance and explains their role in benchmarking, analysis, and portfolio decisions.
23,671 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Inflation remains a dominant force in mid 2026 as weather patterns, AI expansion, and geopolitical tensions push up t...
Traditional media is fading as a pillar of democratic information, pushing investors to rethink exposure and resilien...
In a volatile market, the dividend growth approach that emphasizes rising payouts over big yields is drawing attentio...
Regulators are weighing changes to mortgage asset rules, yet banks may take time to adjust. In the near term, mortgag...
As Johnson & Johnson prepares July earnings, investors weigh the real case buying johnson thesis driven by durable in...
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Amazon stock defies volatility with strong AWS momentum and AI commitments, fueling a growing conviction among trader...
Biotech investing often feels unpredictable. This year, agios stock down year highlights how big investor moves and l...
An elderly investor nearly drained her savings after a deceptive pop-up steered her toward buying gold. This article ...
A regulatory hint sent Moderna stock just popped, but the journey from acceptance to approval matters. This guide bre...
Investing in nuclear energy can feel like riding a high-speed train. Oklo’s small modular reactors promise a greener ...